Notice to Extend the Expiration Date of PA-16-443 "Drug Abuse Dissertation Research (R36)"
Notice NOT-DA-19-073 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 7, 2019 Category: Research Source Type: funding

Notice of Clarification to PAR-19-064, "Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)"
Notice NOT-DA-19-077 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 26, 2019 Category: Research Source Type: funding

Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Well Being, Illness, and Recovery (R01 Clinical Trials Not Allowed)
Grants for research projects that examine how social isolation and social connectedness affect outcomes in health, illness, recovery, and overall well being. Geographic coverage: Nationwide -- National Cancer Institute, National Institute of Mental Health, National Institute on Aging, National Institute on Alcohol Abuse and Alcoholism, National Institute on Drug Abuse, National Institute on Minority Health and Health Disparities, National Institutes of Health, U.S. Department of Health and Human Services (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - September 24, 2019 Category: American Health Source Type: funding

Targeting Inflammasomes in Substance Abuse and HIV (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-DA-20-026 from the NIH Guide for Grants and Contracts. The scientific objective of this Funding Opportunity Announcement is to encourage research to delineate the role of inflammasomes in the neuropathology produced by acute or chronic drug exposure and HIV infection. Understanding the involvement of inflammasomes in virus and drug-induced immune activation may help identify molecular markers and CNS immune cells associated with HIV-1 infection or disease progression among substance abuse populations, as well as identify novel therapies to target inflammasome activation or suppression to treat ne...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 17, 2019 Category: Research Source Type: funding

Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)
Funding Opportunity PAR-19-368 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications proposing the innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of drug using behaviors (defined as alcohol, tobacco, prescription and other drug) and related disorders, prevention of drug use and HIV, and health service utilization. This FOA encourages the analyses of public use and other extant community-based or clinical datasets to their full potential in order to increase...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 9, 2019 Category: Research Source Type: funding

The National Drug Abuse Treatment Clinical Trials Network (UG1 Clinical Trial Required)
Funding Opportunity RFA-DA-20-024 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications from clinical investigators to participate in the National Drug Abuse Treatment Clinical Trials Network (CTN) and contribute to the network's capacity to respond to urgent public health needs. NIDA intends to continue to develop and test interventions for addressing the wide spectrum of substance use problems via collaborative partnerships among NIDA, clinical research investigators, healthcare providers, and healthcare institutions. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 4, 2019 Category: Research Source Type: funding

Notice of Special Interest (NOSI): Epidemiology of Drug Abuse
Notice NOT-DA-19-066 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 29, 2019 Category: Research Source Type: funding

Medication-Assisted Treatment (MAT) Training and Mentoring/DATA 2000 Waiver
Training to provide medication-assisted treatment (MAT) for clinicians in high-need communities. Clinicians who complete the training may be priority applicants for some NHSC loan repayment programs, and qualified disciplines can become eligible for the Loan Repayment Program Continuation Contract MAT Award Enhancement. Geographic coverage: Nationwide -- Bureau of Health Workforce, Health Resources and Services Administration, National Health Service Corps, Substance Abuse and Mental Health Services Administration, U.S. Department of Health and Human Services (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - August 8, 2019 Category: American Health Source Type: funding

Notice of Intent to Publish a Funding Opportunity Announcement for Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)
Notice NOT-DA-19-035 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 17, 2019 Category: Research Source Type: funding

Notice of Special Interest (NOSI): The Application of Big Data Analytics to Drug Abuse Research
Notice NOT-DA-19-041 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 12, 2019 Category: Research Source Type: funding

Behavioral Science Track Award for Rapid Transition (B/Start)(R03 Clinical Trial Optional)
Funding Opportunity PAR-19-310 from the NIH Guide for Grants and Contracts. This Funding Opportunity from the National Institute on Drug Abuse (NIDA) will use a NIH Small Research Grant (R03) award mechanism to support studies that apply affective, cognitive and behavioral science approaches to research questions relevant to substance use disorders (SUD). With this R03 mechanism, NIDA aims to seed innovative affective, cognitive and behavioral hypotheses, models, and methods in preclinical and clinical SUD research. The B/START R03 is intended for recently-independent investigators with expertise in behavioral science a...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 28, 2019 Category: Research Source Type: funding

National Drug Early Warning System Coordinating Center (U01 Clinical Trial Optional )
Funding Opportunity RFA-DA-20-016 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits applications for a single Coordinating Center to support novel data acquisition strategies, data harmonization, analysis and dissemination activities on emerging and current drug abuse trends across the United States. The Coordinating Center will (1) Maintain a Scientific Advisory Group; (2) Maintain and refine an Early Warning Network composed of local experts on drug abuse data from the selected communities, as well as NIDA-supported community-based researchers, to assist in the ongoing m...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 31, 2019 Category: Research Source Type: funding

Notice of Intent to Publish a Funding Opportunity Announcement for The National Drug Abuse Treatment Clinical Trials Network (UG1) Clinical Trial Optional
Notice NOT-DA-19-047 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 22, 2019 Category: Research Source Type: funding

Notice of Correction to PAR-19-246 "Providing Research Education Experiences to Enhance Diversity in the Next Generation of Substance Abuse and Addiction Scientists (R25 - Clinical Trials Not Allowed)"
Notice NOT-DA-19-044 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 21, 2019 Category: Research Source Type: funding

Notice of NIAAA's Participation in PAR-19-246 "Providing Research Education Experiences to Enhance Diversity in the Next Generation of Substance Abuse and Addiction Scientists (R25 - Clinical Trials Not Allowed)
Notice NOT-AA-19-015 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 21, 2019 Category: Research Source Type: funding